Type in any company name or organization to see related SEC FOIA activity. A B7A exemption indicates a potential undisclosed SEC investigation. Learn more in this video.

Stay Updated

Get notified when new results match your search terms

Join ... investors getting FOIAsearch.com alerts on their portfolio
... searches processed so far
Total Results:69,485B7A Results:2,819

Request Types

  • Triage:20,665
  • Exhibit:21,499
  • FOIA:21,268
  • FOIA/PA:1,779
  • Remand:591
  • Consultation:92
  • Office of Government Information Service:1
  • OIG Requests:128
  • Requests for Congressional Records:231
  • Congressional:14
  • COVID-19:177
  • Government Referrals:56
  • FIFO:109
  • First-Party IG Requests:12
  • FOPA:45
  • Not Provided:2,754
  • Chairman Correspondence:23
  • Privacy Act Amendment:16
  • REMD:13
  • CFOI:6
  • OIG:2
  • GOVT:3
  • CHAI:1

Top Organizations

  • Probes Reporter, LLC:16,153
  • Not Provided:12,261
  • AUS Consultants, Inc.:4,419
  • Knowledge Ecology International (KEI):3,960
  • Check Fund Manager, LLC:3,289

Dispositions

  • Denied in Full:4,483
  • Granted in Full:13,886
  • Granted/Denied in Part:1,343
  • Other Reasons:26,794
  • Not Provided:21,599
  • Denied in Full - Referred to the web:1
  • Denied in Full - No information found (appeal rights):3
  • Other Reasons - Cancelled:23
  • Other Reasons - No information found (appeal rights):1,159
  • Other Reasons - Withdrawn:10
  • Other Reasons - Referred to the web:28
  • Other Reasons - Referred to another agency:22
  • Other Reasons - GLOMAR:63
  • Other Reasons - Not an agency record:7
  • Other Reasons - Referred to another office:3
  • Granted in Full - No information found (appeal rights):5
  • Other Reasons - Duplicate Request:39
  • Other Reasons - Not a proper FOIA request for some other reason:5
  • Other Reasons - Records lost or destroyed:2
  • Other Reasons - NIF (c)(1)Exclusion:1
  • Granted/Denied in Part - No information found (appeal rights):1
  • Other Reasons - Records are not reasonably described:3
  • Other Reasons - Moot:1
  • Other Reasons - Referred to Court:2
  • Other Reasons -:1
  • Other Reason:1

All Requests

69,485 results
Requested Date: 6/25/2025Closed Date: 7/7/2025Requester: Shurtz, AlexOrganization: NorstellaType: ExhibitDisposition: Granted in FullRequest ID: 25-02297-E
Description:Exhibit 10.1 to Form 10-Q, filed by Angiotech Pharmaceuticals, Inc., on August 09, 2010
Requested Date: 6/22/2025Closed Date: 7/7/2025Requester: Konanki, ChandanaOrganization: ClarivateType: ExhibitDisposition: Other ReasonsRequest ID: 25-02926-E
Description:Exhibit 10.1 to Form 10-Q, filed by Soliton, Inc., on November 12, 2020
Requested Date: 6/23/2025Closed Date: 7/7/2025Requester: Martin, DianeOrganization: AUS Consultants, Inc.Type: ExhibitDisposition: Granted in FullRequest ID: 25-02961-E
Description:Exhibit 10.38 to Form 10-K, filed by Vivus, Inc., on March 30, 2000
Requested Date: 6/25/2025Closed Date: 7/7/2025Requester: Shurtz, AlexOrganization: NorstellaType: ExhibitDisposition: Granted in FullRequest ID: 25-03000-E
Description:Exhibit 10.1 to Form 10-Q, filed by Nektar Therapeutics, Inc., on November 7, 2013, as previously released in 22-00948-E
Requested Date: 6/25/2025Closed Date: 7/7/2025Requester: Shurtz, AlexOrganization: NorstellaType: ExhibitDisposition: Granted in FullRequest ID: 25-03003-E
Description:Exhibits 10.1, 10.2, and 10.3 to Form 10-Q, filed by Cephalon, Inc., on October 28, 2009, as previously released in 23-00002-E
Requested Date: 6/25/2025Closed Date: 7/7/2025Requester: Shurtz, AlexOrganization: NorstellaType: ExhibitDisposition: Granted in FullRequest ID: 25-03011-E
Description:Exhibit 10.1 to Form 10-Q, filed by AMAG Pharmaceuticals on August 7, 2013, as previously released in 22-00952-E

B7A Exempt Requests

2,819 results
Requested Date: 6/20/2025Closed Date: 6/30/2025Requester: Gavin, J. PatrickOrganization: Probes Reporter, LLCType: TriageDisposition: Denied in FullRequest ID: 25-02539-T
Description:Equinix, Inc.
Requested Date: 1/22/2025Closed Date: 6/26/2025Requester: Laliberte, BrendanOrganization: -Type: FOIADisposition: Granted/Denied in PartRequest ID: 25-01301-FOIA
Description:the efficacy of the SEC Whistleblower Program as a proactive deterrent
Requested Date: 6/12/2025Closed Date: 6/26/2025Requester: Gavin, J. PatrickOrganization: Probes Reporter, LLCType: TriageDisposition: Denied in FullRequest ID: 25-02463-T
Description:CASS Information Systems Inc
Requested Date: 5/22/2025Closed Date: 6/25/2025Requester: Gavin, J. PatrickOrganization: Probes Reporter, LLCType: TriageDisposition: Denied in FullRequest ID: 25-02298-T
Description:United Natural Foods, Inc
Requested Date: 1/22/2025Closed Date: 6/24/2025Requester: Shteyn, VilliOrganization: Pomerantz LLPType: FOIADisposition: Denied in FullRequest ID: 25-01315-FOIA
Description:all records provided to the SEC by Philips concerning the SEC�s investigation of Philips and its executives
Requested Date: 1/25/2025Closed Date: 6/24/2025Requester: Pittman, JeffOrganization: -Type: FOIADisposition: Denied in FullRequest ID: 25-01340-FOIA
Description:all original source documentation submitted to FINRA or the SEC requesting MMTLP to become tradeable on the OTC market in October 2021, names and positions of all individuals and/or groups that applied for or were involved in the process of making MMTLP tradeable, including any broker-dealers who requested the MMTLP symbol from FINRA.